PEMPHIGUS VULGARIS
Clinical trials for PEMPHIGUS VULGARIS explained in plain language.
Never miss a new study
Get alerted when new PEMPHIGUS VULGARIS trials appear
Sign up with your email to follow new studies for PEMPHIGUS VULGARIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take aim at rare blistering disease
Disease control Recruiting nowThis study tests two types of engineered immune cells (CAR T-cells) in 40 adults with active pemphigus vulgaris, a painful blistering skin condition. The goal is to see if these cells can safely control the disease by targeting faulty immune cells. Participants receive a one-time…
Matched conditions: PEMPHIGUS VULGARIS
Phase: PHASE1, PHASE2 • Sponsor: Cabaletta Bio • Aim: Disease control
Last updated May 11, 2026 20:51 UTC
-
Researchers seek to measure the true burden of rare blistering skin diseases
Knowledge-focused Recruiting nowThis study aims to better understand how severe autoimmune blistering diseases like pemphigus and bullous pemphigoid are, and how they affect patients' quality of life. Researchers will enroll 150 adults with these conditions and use special scoring tools to track disease activit…
Matched conditions: PEMPHIGUS VULGARIS
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated May 14, 2026 12:05 UTC